Palavra-chave: SCHISTOSOMIASIS

NANOBIOTECHNOLOGY MALARIA SCHISTOSOMA MANSONI CÔTE D'IVOIRE METHYL BETA CYCLODEXTRIN SCHISTOSOMULA TEGUMENT NATURAL PRODUCT SESQUITERPENES COMPOUNDS LEISHMANIASIS MENTHOL ADENOSINE KINASE SEIZURES AZIGO-PORTAL DISCONNECTION ANTHELMINTIC IMMUNIZATION ADENYLOSUCCINATE LYASE (ADSL) DRUG DISCOVERY TREATMENT. SOLID LIPID NANOPARTICLES SPLENECTOMY RESISTANCE NEGLETED TROPICAL DISEASE RESISTÊNCIA SPATIAL DISTRIBUTION TRYPANOSOMIASIS HEPG2 CELLS STRAINS NANOPARTICLES CYTOTOXICITY CONTROLLED DRUG DELIVERY POLYMERIC NANOCAPSULES IN SILICO DIMINAZENE PHYTOL VACCINE ANTISCHISTOSOMAL COMPOUND TREATMENT IN VITRO BLOOD FLUKE EPILEPSIA BACCHARIS TRIMERA (LESS) DC; NUCLEOSIDE DIPHOSPHATE KINASE (NDPK) DRUG DELIVERY PRAZIQUANTEL ANTHELMINTIC ACTIVITY DERIVADOS DA ARTEMISININA JUVENILE WORMS SCHISTOSOMA MANSONI, INCLUSION COMPLEX RESISTENCE NEGLECTED DISEASES DRUG REPOSITIONING MORPHOLOGY INFECÇÃO DO SISTEMA NERVOSO CENTRAL CYCLODEXTRIN ESQUISTOSSOMOSE CEREBRAL OLEIC ACID